Dr. John A. Chabot

Dr. Chabot founded Columbia’s Pancreas Center in 2006 and has since performed more than 2,500 pancreatic resections, the largest single-surgeon experience in New York State. He couples operative practice with translational research, heading trials that validate serum metabolomic panels and circulating DNA signatures for early pancreatic-cancer detection. His leadership roles—Vice President of ColumbiaDoctors and Chief of HPB Surgery—position him to integrate discoveries rapidly into standard pathways, shortening the lag between bench insight and bedside impact.

 

Scientific output centres on pancreatic-tumour biology, surgical outcomes, and high-risk surveillance. A 2024 case series detailed angiomyolipoma of the distal pancreas, expanding differential diagnosis for incidentalomas. Concurrent Nature reports demonstrated selective RAS-GTP inhibition in pre-clinical pancreatic models, underscoring his bench-to-clinic range. egistries he helped design showed new-onset diabetes predicts progression of low-risk cystic lesions, providing practical algorithms for longitudinal imaging. 

 

Consultations avoid jargon and proceed in discrete modules—diagnosis, operative plan, recovery milestones—to accommodate all literacy levels. A dedicated navigator schedules imaging, nutrition, and anaesthesia assessments within forty-eight hours, reducing pre-operative attrition. Patients receive printed summaries and direct email access, a structure linked to high satisfaction and strong trial enrolment without promotional over-tones.